FAE: Income up 9.7% YoY, adjusted EBITDA up 3%, net profit down 6.8%; LATAM leads growth
· Issued by Faes Farma, S.A.
Income grew 9.7% year-over-year, led by strong pharma and licensing growth, while adjusted EBITDA rose 3% and net profit declined 6.8%. LATAM and Animal Nutrition segments outperformed, and 2025 guidance anticipates continued income growth but lower reported EBITDA.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.
